Teneligliptin-Glimepiride DDI Study

Condition:   Diabetes Mellitus Intervention:   Drug: Teneligliptin+Glimepiride Sponsor:   Handok Pharmaceuticals Co., Ltd. Not yet recruiting - verified December 2016

Source: ClinicalTrials.gov - December 28, 2016 Category: Research Source Type: clinical trials